Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neurofibromatosis 1 2Neoplasms 2Smoking Cessation 1Smoking 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Follicular 1Head and Neck Neoplasms 1Fatigue 1Cognition Disorders 1Carcinoma, Hepatocellular 1Cancer Pain 1Breast Neoplasms 1Bone Neoplasms 1Anxiety Disorders 1Anti-N-Methyl-D-Aspartate Receptor Encephalitis 1Agnosia 1Abdominal Pain 1

Interventions

Lovastatin 3Deoxycholic Acid 3AZD 6244 3pirfenidone 2Vinblastine 2Transcranial Direct Current Stimulation 2Sirolimus 2Polidocanol 2Lasers, Solid-State 2Inhalation 2Acetylcysteine 2tipifarnib 1pomalidomide 1peginterferon alfa-2b 1mirdametinib 1diphenylcyclopropenone 1binimetinib 1X-Rays 1Vincristine 1Temozolomide 1Surveys and Questionnaires 1Sunitinib 1Specimen Handling 1Sorafenib 1Saline Solution 1Ranibizumab 1Radiotherapy 1Photons 1Pharmacokinetics 1Neuropsychological Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neurofibromatosis 1 × Transcranial Direct Current Stimulation × Clear all
NCT04991428 2021-08-05

Mechanism of Action of Transcranial Direct Current Stimulation in Neurofibromatosis Type 1

University of Manchester

Phase NA Completed
31 enrolled
CNS

Neurofibromatosis 1

NCT03310996 2019-04-24

tDCS is NF1

University of Manchester

Phase NA Completed
16 enrolled
CNS

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡